A Trans-Atlantic Perspective on the 2025 AHA/ACC Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
for Preventive Cardiology Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults 1 represent the first major update since 2017, incorporating new evidence and offering updated recommendations for high blood pressure (BP) management.These US guidelines closely follow 2 distinct European updates: the 2023 European Society of Hypertension (ESH) 2 and the 2024 European Society of Cardiology (ESC) 3 guidelines.Whereas all 3 aim to reduce hypertension-related morbidity and mortality by recommending evidence-based care, there are important differences.
Authors
- Stephen Paul Juraschek (ORCID: https://orcid.org/0000-0003-4168-2696)
- Michel Azizi (ORCID: https://orcid.org/0000-0003-0597-8318)
Institutions
- Beth Israel Deaconess Medical Center (US)
- Inserm (FR)
- Université Paris Cité (FR)
- Sorbonne Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Hôpital Européen (FR)
Publication Details
- Journal
- Circulation
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1161/circulationaha.125.075742
- Citations
- 3
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- American Heart Association
- AstraZeneca
- Alnylam Pharmaceuticals
- ReCor Medical
- Novo Nordisk
- Servier
- National Institutes of Health